RxDoctor Payments Data

Katherine Durnen, MD

Plastic and Reconstructive Surgery · Bowling Green, KYNPI 1386986040

Payments from drug & device makers

What this record shows

The money is spread across several categories — food and beverage (53.4%), travel and lodging and consulting fees — rather than concentrated in one kind of arrangement. 18 manufacturers reported payments, led by AbbVie at 35.5% of the total. 2025 is the largest year on record at $4,791, 8.4 times the $569 reported in 2019.

$11,393in general payments, 2019–2025

Across 207 payments — averaging $55.04 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$4K
  • TELA Bio, Inc.$4K
  • Sientra, Inc.$864
  • Revance Therapeutics, Inc.$619
  • Motiva USA, LLC$510
  • RTI Surgical, Inc$296
  • plus $1K from 12 others

What the payments were for

  • Consulting fees$1,0009%
  • Travel & lodging$4,19737%
  • Food & beverage$6,08653%
  • Education$230%
  • Gifts$871%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$11,393 in reported general payments places this provider in the 80th percentile of 43 plastic and reconstructive surgery providers in Kentucky.

See all plastic and reconstructive surgery providers in Kentucky

Medicare billing

Part B allowed, 2024
$32,690
Medicare patients
54
Services billed
140

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Silver Sulfadiazine16$238
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen26$123
Ondansetron OdtOndansetron12$120
Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen31$118
Cephalexin12$112
SsdSilver Sulfadiazine11$86

Paid to pharmacies, not to this prescriber.

Other plastic and reconstructive surgery in Bowling Green

See the full list for Kentucky

Where these figures come from

Is this you, or does something look wrong? →